Shilpa Pharma Lifesciences Limited, a subsidiary of Shilpa Medicare Limited, has recently been awarded the EcoVadis Gold Medal for its outstanding commitment to sustainability, achieving an impressive score of 82/100. This remarkable performance places the company in the 98th percentile globally, among over 130,000 companies evaluated by EcoVadis, a leading provider of business sustainability ratings. The recognition reflects Shilpa's dedication to Environmental, Social, and Governance (ESG) practices, highlighting its long-term vision of establishing a responsible and sustainable pharmaceutical enterprise.

EcoVadis assesses organizations based on four key pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. Shilpa Pharma Lifesciences' recognition as a top-rated company for sustainable business operations underscores its commitment to these principles. Mr. Keshav Bhutada, Executive Director and CEO of Shilpa Pharma Lifesciences, emphasized that sustainability and innovation are central to the company's growth strategy, particularly in collaborating with global innovators on new chemical entity programs. He stated that the Gold Medal is a testament to the company’s relentless efforts in responsible manufacturing and ethical governance.

This accolade not only enhances Shilpa's reputation but also strengthens its relationships with global customers, investors, and partners. By reinforcing its position as a trusted Contract Development and Manufacturing Organization (CDMO), Shilpa Pharma Lifesciences aims to continue prioritizing sustainability within its operations. The achievement signals a commitment to creating enduring value for patients and partners alike, as the company looks forward to expanding its collaborations with more global innovator companies in the pharmaceutical sector.